Novel capsid binder and PI4KIIIbeta inhibitors for EV-A71 replication inhibition.

ABSTRACT: The Hand, Foot and Mouth Disease (HFMD) is a highly contagious viral illness generally manifests as a mild disease in young children and immunocompromised adults. It has however emerged as a significant public health threat in recent years as outbreaks have been occurring regularly, especially in the Asia-Pacific. The disease can result from infections by a wide variety of human enteroviruses, particularly, Enterovirus A71 (EV-A71) has garnered more attention due to its association with severe disease in infected patients. Despite the potential to result severe neurological complications or even fatality, there is currently no effective antiviral for treatment of EV-A71 infections and the only vaccines available are restricted to distribution in China. In this study, we report the in vitro

SUBMITTER: Tan YW 

PROVIDER: S-EPMC8102518 | biostudies-literature | 2021 May

REPOSITORIES: biostudies-literature